# Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

> **NCT07281599** · NA · RECRUITING · sponsor: **Qurasense** · enrollment: 450 (estimated)

## Conditions studied

- HPV Infection
- HPV 16 Infection
- High Risk HPV
- Cervical Cancer Screening
- Cervical Cancer Cin Grade
- Cervical Cancer (Early Detection)
- HPV
- HPV (Human Papillomavirus)-Associated
- HPV DNA
- HPV Infections
- Screening Test

## Interventions

- **DEVICE:** Q-Pad hrHPV Test System

## Key facts

- **NCT ID:** NCT07281599
- **Lead sponsor:** Qurasense
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07281599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07281599, "Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07281599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*